Elite Hlth Sys Stock Price, News & Analysis

Elite Health Systems Inc. (EHSI) is a Delaware corporation whose common stock is held by public stockholders and subject to U.S. Securities and Exchange Commission (SEC) reporting requirements. According to its SEC filings, the company is referred to as “Elite,” “we,” “us,” “our” or the “Company” and conducts formal stockholder meetings, maintains a Board of Directors, and issues common stock to investors. Its securities are not registered under Section 12(b) of the Securities Exchange Act of 1934, as recent filings state that no securities are registered pursuant to that section.

Elite Health Systems Inc. provides stockholders with voting rights on key corporate matters through special meetings of stockholders. These meetings are held virtually over the internet, allowing eligible stockholders of record to participate and vote electronically. The company’s proxy materials describe proposals that are submitted to stockholders, including the election of directors, amendments to its Certificate of Incorporation, approval of equity incentive plans, approval of acquisition-related share issuances, ratification of independent auditors, and potential adjournment of meetings to solicit additional proxies.

In its definitive proxy statement filed as a Schedule 14A, Elite Health Systems Inc. outlines a Special Meeting of Stockholders to be held virtually. Stockholders of record as of a specified record date are entitled to notice of, and to vote at, this meeting. The proxy statement explains that each holder of the company’s common stock is entitled to one vote per share and describes how proxies may be authorized by mail, telephone or over the internet. It also discusses quorum requirements, voting standards for each proposal, and the treatment of broker non-votes and abstentions.

The company’s governance framework, as described in the proxy statement, includes a Board of Directors whose members are elected by stockholders for one-year terms, subject to stockholder approval. Proposals presented to stockholders include:

• Election of five director nominees to the Board of Directors for a term expiring at the next annual meeting of stockholders.
• An amendment to the Certificate of Incorporation to increase the aggregate number of authorized shares of common stock from 25,000,000 shares to 50,000,000 shares.
• Approval of a 2025 Equity Incentive Plan with a maximum aggregate number of 4,500,000 shares of common stock subject to the plan.
• Approval of the acquisition of Physician Support Systems, Inc. (PSS) by issuing 3,158,000 shares of the company’s common stock pursuant to a share exchange agreement.
• Ratification of the appointment of Mercurius & Associates LLP as independent auditors for the fiscal year ending December 31, 2025.
• Approval of a possible adjournment of the meeting to solicit additional proxies if deemed necessary or appropriate by the chairperson.

An accompanying Current Report on Form 8-K describes the outcome of a Special Meeting of Stockholders held on September 26, 2025. At that meeting, a quorum of shares was present or represented by proxy, and stockholders voted on the same categories of proposals described in the proxy statement. The 8-K details the number of votes cast for and against each proposal, as well as abstentions or withheld votes, and confirms that the proposals received sufficient support to pass where applicable, including the election of five directors, the increase in authorized common stock, approval of the 2025 Equity Incentive Plan, approval of the PSS acquisition share issuance, ratification of Mercurius & Associates LLP as independent auditors, and approval of the potential adjournment of the meeting.

The Form 8-K also describes the entry into a Share Exchange Agreement with Physician Support Systems, Inc. and its stockholders. Under this agreement, Elite Health Systems Inc. agreed to acquire 100% of the outstanding capital stock of PSS in exchange for 3,158,000 shares of the company’s common stock. The transaction is subject to several conditions, including stockholder approval of the exchange agreement, stockholder approval of the amendment to increase authorized common stock, and satisfaction of closing conditions and deliverables such as the issuance of shares and delivery of secretary certificates.

Elite Health Systems Inc. uses equity-based compensation, as reflected in the 2025 Equity Incentive Plan proposal, which sets a maximum aggregate number of shares of common stock that may be issued under the plan. This plan, subject to stockholder approval, is intended to govern the issuance of equity awards, which may align the interests of directors, officers, employees or other eligible participants with those of stockholders, as described in the proxy statement.

From a corporate governance perspective, Elite Health Systems Inc. emphasizes formal stockholder engagement through proxy materials that explain the purpose of each proposal, the voting process, and the implications of various voting outcomes. The proxy statement also provides a question-and-answer section for stockholders, clarifying why they are receiving the proxy statement, what matters they are being asked to vote on, how to vote, and how broker non-votes are treated under applicable exchange interpretations.

According to the address information contained in its SEC filings, Elite Health Systems Inc. lists its location in Ontario, California. The company identifies itself as a Delaware corporation and provides notice that only holders of record of its common stock as of a specified record date are entitled to notice of and to vote at its special meeting. The filings also note that its securities are not listed on a national securities exchange under Section 12(b) of the Exchange Act.

Investors reviewing Elite Health Systems Inc. can use these filings to understand how the company manages its capital structure, plans for potential acquisitions through share exchanges, and engages independent auditors. The filings also show how the company uses virtual meeting technology and electronic voting platforms to facilitate participation by stockholders.

Key corporate actions highlighted in recent filings

• Special Meeting of Stockholders with multiple governance and capital structure proposals.
• Proposal and subsequent approval to increase authorized common stock from 25,000,000 to 50,000,000 shares.
• Proposal and approval of a 2025 Equity Incentive Plan covering up to 4,500,000 shares.
• Entry into, and stockholder approval of, a Share Exchange Agreement to acquire Physician Support Systems, Inc. in exchange for 3,158,000 shares of common stock, subject to closing conditions.
• Ratification of Mercurius & Associates LLP as independent auditors for the fiscal year ending December 31, 2025.
• Authorization to adjourn the Special Meeting if necessary to solicit additional proxies.

These elements, as described in the company’s Form 8-K and definitive proxy statement, provide insight into Elite Health Systems Inc.’s approach to corporate governance, capital planning, and acquisition strategy.

Frequently referenced terms in Elite Health Systems Inc. filings

• Special Meeting of Stockholders: A meeting called to vote on specific proposals, including director elections, amendments to the Certificate of Incorporation, equity plans, acquisitions, auditor ratification and adjournment authority.
• Authorized Shares Increase Proposal: A proposal to amend the Certificate of Incorporation to increase the total number of authorized shares of common stock.
• 2025 Equity Incentive Plan Proposal: A proposal to approve an equity incentive plan with a defined maximum number of shares available for issuance.
• Acquisition Proposal: A proposal to approve the acquisition of Physician Support Systems, Inc. through a share exchange agreement.
• Approval of Independent Auditor Proposal: A proposal to ratify the appointment of Mercurius & Associates LLP as independent auditors.
• Adjournment Proposal: A proposal to allow adjournment of the meeting to solicit additional proxies if deemed necessary.